Skip to main content

Pentraxin 3 as a marker of vasospasm following subarachnoid hemorrhage

Introduction

We studied the induction of Pentraxin 3 (PTX3), a prototypic long pentraxin protein induced by proinflammatory signals in subarachnoid hemorrhage (SAH) patients, to investigate a possible relation with SAH-associated ischemic brain damage.

Methods

PTX3 was measured in the plasma and cerebrospinal fluid (CSF) of 38 SAH patients admitted to the neuroscience ICU, who were divided into three groups: occurrence of vasospasm, defined as neuro-worsening (loss of at least one point of the Glasgow Coma Scale motor component and/or appearance of a new focal deficit) and angiographic confirmation of vasospasm; presence of an early hypodense lesion, defined as the appearance of a new hypodense lesion at CT scan following endovascular or surgical treatment, or around the initial intracerebral hematoma; and absence of a hypodense lesion. Arterial and CSF samples were obtained every 12 hours starting on the day of SAH and up 2 weeks post SAH.

Results

PTX3 was induced in the plasma and CSF of SAH patients. CSF peak concentrations were significantly higher in patients with vasospasm (21.5 ± 5.1 ng/ml) compared with those with no CT hypodense lesion (5.8 ± 4.5 ng/ml, P < 0.05). Patients with an early hypodense lesion showed a peak concentration that was intermediate between the other two groups (12.4 ± 5.2 ng/ml). No difference was observed in plasma levels among the three groups. The temporal pattern of CSF PTX3 in patients with vasospasm was triphasic: there was an initial increase of PTX3 during the first 48 hours following SAH (acute phase, up to 17.2 ± 5.2 ng/ml), followed by a subsequent decrease in the next 48–96 hours (subacute phase, up to 1.2 ± 0.3 ng/ml, P < 0.01 compared with the acute phase). With the appearance of vasospasm, a secondary peak of PTX3 was detected (up to 7.1 ± 1.4 ng/ml, P < 0.01 compared with the subacute phase). No changes were detectable in plasma.

Conclusion

PTX3 is induced in the CSF and in plasma following SAH; however, the CSF but not plasma levels are directly related to the degree of brain injury. In addition the data show that PTX3 measured in the CSF might be a reliable marker of vasospasm following SAH, and suggest that measurements of PTX3-CSF levels associated with clinical evaluation could improve early diagnosis of vasospasm in these patients.

Author information

Affiliations

Authors

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Zanier, E., Peri, G., Brandi, G. et al. Pentraxin 3 as a marker of vasospasm following subarachnoid hemorrhage. Crit Care 12, P113 (2008). https://doi.org/10.1186/cc6334

Download citation

Keywords

  • Acute Phase
  • Subarachnoid Hemorrhage
  • Glasgow Coma Scale
  • Ischemic Brain
  • Secondary Peak